and used the index drug for 90 days (with 60-day gaps)
On the other hand, the risks of HHF (HR 0.93, 95% CI 0.831.04 with GLP-1RAs and HR 0.69, 95% CI 0.610.79 with SGLT2is) and composite kidney outcomes excluding macroalbuminuria (HR 0.92, 95% CI 0.801.06 with GLP-1RAs and HR 0.55, 95% CI 0.480.64 with SGLT2is) significantly reduced with SGLT2is only
Some users see dramatic initial drops of 6 to 8 pounds, but this largely represents water and digestive contents rather than true fat loss
Results will vary depending on the medication, your dose, and how long you stay on treatment, but studies in non-diabetic patients consistently show strong outcomes
Endometrial microbiota did not appear to cluster by disease status (endometriosis vs
It amplifies GH pulses triggered by CJC-1295 without the cortisol or prolactin elevation seen with older GHRPs like GHRP-6 or Hexarelin